US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Fractyl Health Inc (GUTS)
Fractyl Health Inc (GUTS) ニュース

GUTS

Fractyl Health (GUTS)

Fractyl Health Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:GUTS

1

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/29	20 : 00	GlobeNewswire Inc.	Fractyl Health to Present New Preclinical Obesity Data from Rejuva® Platform at the American Diabetes Association’s 84th Scientific Sessions	NASDAQ:GUTS	Fractyl Health Inc
2024/05/20	19 : 00	GlobeNewswire Inc.	Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva® at Digestive Disease Week 2024	NASDAQ:GUTS	Fractyl Health Inc
2024/05/15	05 : 15	Edgar (US Regulatory)	Form 3/A - Initial statement of beneficial ownership of securities: [Amend]	NASDAQ:GUTS	Fractyl Health Inc
2024/05/14	05 : 06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:GUTS	Fractyl Health Inc
2024/05/14	05 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GUTS	Fractyl Health Inc
2024/05/14	05 : 00	GlobeNewswire Inc.	Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates	NASDAQ:GUTS	Fractyl Health Inc
2024/05/13	19 : 00	GlobeNewswire Inc.	Fractyl Health Presents Clinical Update on Revita® German Real-World Registry for Patients With Advanced Type 2 Diabetes (T2D)	NASDAQ:GUTS	Fractyl Health Inc
2024/05/08	19 : 00	GlobeNewswire Inc.	Fractyl Health to Present at BofA Securities 2024 Health Care Conference	NASDAQ:GUTS	Fractyl Health Inc
2024/05/07	19 : 00	GlobeNewswire Inc.	Fractyl Health to Report First Quarter 2024 Financial Results and Provide Business Updates on May 13, 2024	NASDAQ:GUTS	Fractyl Health Inc
2024/04/30	21 : 38	GlobeNewswire Inc.	Fractyl Health Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference and the German Diabetes Association (DDG) Annual Meeting	NASDAQ:GUTS	Fractyl Health Inc
2024/04/02	21 : 00	GlobeNewswire Inc.	Fractyl Health Expands Leadership with Appointment of Adrian Kimber as Chief Commercial Officer to Spearhead Anticipated Launch Preparation as the Company Conducts Two Pivotal Studies for Revita in Obesity and Type 2 Diabetes	NASDAQ:GUTS	Fractyl Health Inc
2024/04/01	20 : 00	GlobeNewswire Inc.	Fractyl Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NASDAQ:GUTS	Fractyl Health Inc
2024/04/01	19 : 00	GlobeNewswire Inc.	Fractyl Health Receives FDA IDE Approval for the Revita® Remain-1 Pivotal Study of Weight Maintenance in Obesity after Discontinuation of GLP-1 Based Drugs	NASDAQ:GUTS	Fractyl Health Inc
2024/03/13	03 : 06	GlobeNewswire Inc.	UPDATE -- Fractyl Health Announces New Results From Its Rejuva® Platform Demonstrating Potent and Durable Effects of a Single Dose of a Human GLP-1 Pancreatic Gene Therapy Transgene Compared to Semaglutide in the db/db Mouse Model of Diabetes and Obesity	NASDAQ:GUTS	Fractyl Health Inc
2024/03/12	21 : 38	GlobeNewswire Inc.	Fractyl Health Announces New Results From Its Rejuva® Platform Demonstrating Potent and Durable Effects of a Single Dose of a Human GLP-1 Pancreatic Gene Therapy Transgene Compared to Semaglutide in the db/db Mouse Model of Diabetes and Obesity	NASDAQ:GUTS	Fractyl Health Inc
2024/02/20	22 : 38	GlobeNewswire Inc.	Fractyl Health Appoints Samuel Conaway to Its Board of Directors, Bolstering New Product Commercial Expertise During Revita® Pivotal Clinical Trials	NASDAQ:GUTS	Fractyl Health Inc
2024/02/02	10 : 08	GlobeNewswire Inc.	Fractyl Health Announces Pricing of Initial Public Offering	NASDAQ:GUTS	Fractyl Health Inc

Showing the most relevant articles for your search:NASDAQ:GUTS

1

Farmland Partners

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約